Ashvin raises $16.5M to automate medical equipment intake
What's the deal? AshvinDealroom has a profile for this one. Try Dealroom →, a Boston startup that automates intake for durable medical equipment (DME) providers, has raised $16.5 million in an early-stage round. The investment was led by co-founder Mathew Mammen, with participation from industry leaders, and was announced on October 12, 2026.
What's the endgame? Ashvin's software reads referrals sent by fax or upload, verifies insurance, and checks documentation against payer requirements before sending qualified orders into a provider's billing system. The process typically takes about 10 minutes. For some customers, 64% of orders ship without any staff handling at all.
By the numbers: Ashvin says it has grown revenue sixfold since emerging from stealth last year. Bellevue Healthcare, a Pacific Northwest provider, said Ashvin helped cut denial rates by 32% and freed staff from manual referral work. Another customer passed a third-party administrator audit with no findings.
Why now? DME providers face rising demand, lower reimbursement, and staffing shortages. Intake errors can trigger denied claims, delayed payments, and audit findings months later — problems that are cheaper to fix before an order ships.
What's next? The company, founded in 2024, will use the capital to build new capabilities, starting with prior authorization — one of the most manual parts of DME revenue cycle work. It also plans to expand across the US DME market.
The signal: The raise reflects investor appetite for workflow automation that heads off costly claim problems in reimbursement-heavy healthcare. Mammen's background in DME sales lends the pitch direct industry credibility, and Ashvin's push into prior authorization signals it is moving deeper into the sector's thorniest paperwork.
Read more: usdailyledger.com
Image credit: Like us on Facebook at CAGuard
